A recent study showed that TAB1 undergoes O-GlcNAcylation in vivo in response to hyperglycemia as well as IL-1 and osmotic stress, demonstrating that TAB1 O-GlcNAcylation is controlled by activators of TAK1 signaling [15]. This evidence concerns the gene TAB1 and Hyperglycemia.